These results showed that Fn growth was significantly inhibited when treated with sera from CRC patients with a high titre of anti-AhpC IgG and IgA, while Fn growth in sera from healthy subjects was not inhibited (Fig. 6D). This evidence concerns the gene FN1 and colorectal carcinoma.